Sinopharm Tag

17 February 2022 Embargo: Immediate release Until recently, the treatment options for patients with mild-to-moderate COVID-19 have been limited. New oral antiviral medicines are becoming available for the treatment of confirmed COVID-19 in adults who do not require supplemental oxygen and who are at risk of...

Embargo: Immediate release SAHPRA registered two COVID-19 vaccines: the COMIRNATY vaccine by Pfizer Laboratories (Pty) Ltd on 25 January 2022, and the COVID-19 VACCINE MC PHARMA by MC Pharma (Pty) Ltd. on 31 January 2022. Both vaccines have been registered in terms of section 15 of...

7 February 2022 SAHPRA registered the SAHPRA registered the Comirnaty vaccine from Pfizer Laboratories Pty (Ltd) on 25 January 2022, with conditions. SAHPRA also SAHPRA registered the Covid-19 Vaccine MC Pharma on 31 January 2022, with conditions. SAHPRA is currently also evaluating a number of applications for...

21 June 2021 The South African Health Products Regulatory Authority (SAHPRA) is an independent health products regulatory authority, governed by national legislation, whose mandate is to ensure the safety, quality and efficacy of health products available in South Africa. These essential requirements have been similarly applied...